Cowen Starts Acadia Pharmaceuticals (ACAD) at Outperform

Cowen initiated coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with an Outperform rating and a price target of $46.00.

For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.

Shares of Acadia Pharmaceuticals closed at $27.74 yesterday.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Pepsico (PEP) PT Lowered to $150 at TD Cowen
• Freedom Broker Starts Comcast Corp (CMCSA) at Hold